Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma.
Sjögren's syndrome is a chronic autoimmune disease affecting exocrine glands, resulting in xerostomia and xerophthalmia. Lymphocytic infiltration and fibrosis of exocrine glands as well as the presence of autoantibodies against organ-specific and non-organ-specific antigens are the hallmarks of the disease. We investigated whether some patients affected by Sjögren's syndrome might have autoantibodies directed against epithelial duct cell membrane proteins. We screened sera from patients affected by Sjögren's syndrome by indirect immunofluorescence on monkey salivary gland sections and FG-Met-2 cells (a pancreatic carcinoma cell line with ductal features) for the presence of antisalivary duct antibodies. Positive sera were employed in immunoprecipitation experiments on (35)S-methionine in vivo labeled and surface-biotinylated FG-Met-2 cells. The serum of a patient affected by Sjögren's syndrome and gastric mucosa-associated lymphoid tissue (MALT) lymphoma gave positive and distinct membrane immunostaining on FG-Met-2 cells. Immunoprecipitation with the patient's serum from (35)S-methionine-labeled cell extracts followed by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) and autoradiography showed the presence of autoantibodies against a 72-kDa protein. After biotin-surface labeling of FG-Met-2 cells, a band with identical electrophoretic mobility was immunoprecipitated by the serum, demonstrating that the 72-kDa band is a membrane glycoprotein. We demonstrated by three complementary approaches, i.e., immunocytochemistry, (35)S-methionine in vivo labeling, and cell surface biotinylation, the presence of autoantibodies directed against a duct cell membrane protein of 72-kDa in a patient affected by Sjögren's syndrome and gastric MALT lymphoma. Autoantibodies directed against this novel membrane autoantigen may be an additional serological marker in some cases of Sjögren's syndrome.
Folli
F
F
Department of Medicine I, I.R.C.C.S. H.S. Raffaele, Via Olgettina, 60, 20132 Milan, Italy. folli.franco@hsr.it
Perego
L
L
Ponzoni
M
M
Girardi
A M
AM
Bosi
E
E
Ferreri
A J M
AJ
Bellone
M
M
Sabbadini
M G
MG
Vicari
A M
AM
Trusolino
L
L
D000368:Aged; D001323:Autoantibodies / Q000097:blood*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D018442:Lymphoma, B-Cell, Marginal Zone / Q000209:etiology* / Q000276:immunology*; D008562:Membrane Glycoproteins / Q000276:immunology* / Q000302:isolation & purification; D008970:Molecular Weight; D011233:Precipitin Tests; D018987:Salivary Ducts / Q000737:chemistry* / Q000166:cytology / Q000648:ultrastructure; D012859:Sjogren's Syndrome / Q000150:complications / Q000209:etiology / Q000276:immunology*; D013274:Stomach Neoplasms / Q000209:etiology / Q000276:immunology*
D001323:Autoantibodies; D008562:Membrane Glycoproteins